631 filings
Page 9 of 32
8-K
8ksphg07cnczdl9238d
17 Mar 17
BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results
12:00am
8-K
dee589
27 Feb 17
BioDelivery Sciences Secures Debt Financing with CRG
12:00am
8-K
nte5kskae 51a9
9 Jan 17
Other Events
12:00am
8-K
63p9ea40g2c
13 Dec 16
BioDelivery Sciences Announces Clonidine Topical Gel for Painful Diabetic
12:00am
8-K
jiilot2 19lhw9qz
13 Dec 16
BELBUCA expected to be accretive to BDSI’s 2017 net income and EPS
12:00am
8-K
r17 700qp3cff8p
9 Nov 16
Reports Third Quarter 2016 Financial Results
12:00am
8-K
d92oe
1 Nov 16
BioDelivery Sciences to Host Conference Call and Webcast Reporting Third Quarter 2016 Financial Results on Wednesday, November 9
12:00am
8-K
uj4v 73bpnsgw36
24 Oct 16
BioDelivery Sciences Announces Preferred Formulary Status for BUNAVAIL
12:00am
8-K
97pxrjyie5i
5 Oct 16
BioDelivery Sciences Announces Additions to its Board of Directors
12:00am
CT ORDER
8twzgj akxs2fh9
21 Sep 16
Confidential treatment order
12:00am
8-K
q01nyjl 6jq40m0dz
19 Sep 16
BioDelivery Sciences Announces Three New Managed Care Agreements; Further Enhancing Access to BUNAVAIL
12:00am
8-K
6dp6lz
9 Aug 16
Reports Second Quarter 2016 Financial Results
12:00am
8-K
grsgli x5y8du
4 Aug 16
Other Events
12:00am
8-K
um4dk
12 Jul 16
BioDelivery Sciences Announces the Securing of Preferred Formulary Status
12:00am
8-K
z6ho2xwn8sez
1 Jul 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
7wa5a5
17 May 16
BioDelivery Sciences and Collegium Pharmaceutical Announce the Signing of a Licensing
12:00am